Thorel, Lucie
Divoux, Jordane
Lequesne, Justine
Babin, Guillaume
Morice, Pierre-Marie
Florent, Romane
Desmartin, Guillaume
Lecouflet, Lucie
Marde Alagama, Chloé
Leconte, Alexandra
Clarisse, Bénédicte
Briand, Mélanie
Rouzier, Roman
Gaichies, Léopold
Martin-Françoise, Sandrine
Le Brun, Jean-François
Denoyelle, Christophe
Vigneron, Nicolas
Jeanne, Corinne
Blanc-Fournier, Cécile
Leman, Raphaël
Vaur, Dominique
Figeac, Martin
Meryet-Figuiere, Matthieu
Joly, Florence
Weiswald, Louis-Bastien
Poulain, Laurent
Dolivet, Enora
Funding for this research was provided by:
Région Normandie (ORGATHEREX)
Canceropole Nord-Ouest, France (ORGRAFT)
Fondation de l’Avenir (AP-RM-19-020)
Fondation ARC pour la Recherche sur le Cancer (PJA20191209649)
Ligue Contre le Cancer
Article History
Received: 24 April 2024
Accepted: 24 May 2024
First Online: 7 June 2024
Declarations
:
: This study has received ethical approval from the Comité de Protection des Personnes Est IV (N°EudraCT: 2018-A02152-53) in January 2019 with last amendment (V4) accepted in March 2023. This committee is independent and not related with any affiliation of the authors. Any subsequent will of modification of the protocol would be submitted to agreement of the committee. The clinical trial has been registered at ClinicalTrials.gov with the identifier NCT03831230 on January 28th, 2019. The study will be explained to the patients by the surgeons or the oncologists, who will give them an information file. All patients will consent to be part of the study by giving their informed non-opposition.
: Not applicable.
: The authors declare no competing interests.